FDMT position history
The shares of 4D Molecular Therapeutics In (FDMT) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q4: 229,000 shares, $5M, 1.1% of portfolio, New
- 2022 Q1: 325,000 shares, $4.9M, 1.5% of portfolio, Add +41.9%
- 2022 Q2: 325,000 shares, $2.3M, 1.0% of portfolio
- 2022 Q3: 350,700 shares, $2.8M, 1.2% of portfolio, Add +7.9%
- 2022 Q4: 330,000 shares, $7.3M, 2.5% of portfolio, Reduce −5.9%
- 2023 Q1: 314,000 shares, $5.4M, 1.6% of portfolio, Reduce −4.8%
- 2023 Q2: 221,700 shares, $4M, 0.96% of portfolio, Reduce −29.4%
- 2023 Q3: 308,500 shares, $3.9M, 1.3% of portfolio, Add +39.2%
- 2023 Q4: 308,500 shares, $6.3M, 1.7% of portfolio
- 2024 Q1: 688,246 shares, $22M, 4.9% of portfolio, Add +123.1%
- 2024 Q2: 345,750 shares, $7.3M, 1.7% of portfolio, Reduce −49.8%
- 2024 Q3: not held, Exit
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: not held
- 2026 Q1: 112,291 shares, $1M, 0.14% of portfolio, New
- 2026 Q2: 334,437 shares, $4.4M, 0.40% of portfolio, Add +197.8%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|